Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia

Annals of the New York Academy of Sciences

Volumn 1003, Issue , 2003, Pages 94-101

  Harrison, Paul J ^a,b   Law, Amanda J ^a   Eastwood, Sharon L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

AMPA receptor; Gene expression; Kainate receptor; Lateralization; Medial temporal lobe; mRNA; NMDA receptor

Indexed keywords

AMINO ACID TRANSPORTER; AMPA RECEPTOR; BIOLOGICAL MARKER; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT; VESICULAR TRANSPORT PROTEIN;

AUTOPSY; CONFERENCE PAPER; GENETIC SUSCEPTIBILITY; HEMISPHERIC DOMINANCE; HIPPOCAMPUS; HUMAN; MOLECULAR BIOLOGY; NEUROPATHOLOGY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRESYNAPTIC NERVE; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR GENE; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; TEMPORAL LOBE;

EID: 0141532459     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1300.006     Document Type: Conference Paper

References (43)

1. OLNEY, J.W. & N.B. FARBER. 1995. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52: 998-1007.
2. TAMMINGA, C.A. 1998. Schizophrenia and glutamatergic transmission. Crit. Rev. Neurobiol. 12: 21-36.
3. TSAI, G. & J.T. COYLE. 2002. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 42: 165-179.
4. CARLSSON, A., N. WATERS, S. HOLM-WATERS, et al. 2001. Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence. Annu. Rev. Pharmacol. Toxicol. 41: 237-260.
5. BRESSAN, R.A. & L.S. PILOWSKY. 2000. Imaging the glutamatergic system in vivo - relevance to schizophrenia. Eur. J. Nucl. Med. 27: 1723-1731.
6. HARRISON, P.J. 1996. Advances in post mortem molecular neurochemistry and neuropathology: examples from schizophrenia research. Br. Med. Bull. 52: 527-538.
7. BURNET, P.W.J., S.L. EASTWOOD & P.J. HARRISON. 2003. Laser-assisted microdissection: methods for the molecular analysis of psychiatric disorders at a cellular resolution. Biol. Psychiatry. In press.
8. MEADOR-WOODRUFF, J.H. & D.J. HEALY. 2000. Glutamate receptor expression in schizophrenic brain. Brain Res. Rev. 31: 288-294.
9. KONRADI, C. & S. HECKERS. 2003. Molecular aspects of glutamate dysfunction: implications for schizophrenia and its treatment. Pharmacol. Therap. 97: 153-179.
10. KERWIN, R.W., S. PATEL & B. MELDRUM. 1990. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39: 25-32.
11. GAO, X-M., K. SAKAI, R.C. ROBERTS, et al. 2000. Iontropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J. Psychiatry 157: 1141-1149.
12. LAW, A.J. & J.F.W. DEAKIN. 2001. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 12: 2971-2974.
13. HARRISON, P.J., D. MCLAUGHLIN & R.W. KERWIN. 1991. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337: 450-452.
14. EASTWOOD, S.L., B. MCDONALD, P.W.J. BURNET, et al. 1995. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Mol. Brain Res. 29: 211-223.
15. EASTWOOD, S.L., R.W. KERWIN & P.J. HARRISON. 1997. Immuno-autoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl- 4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol. Psychiatry 41: 636-643.
16. EASTWOOD, S.L., P.W.J. BURNET & P.J. HARRISON. 1997. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Mol. Brain Res. 44: 92-98.
17. PORTER, R.H.P., S.L. EASTWOOD & P.J. HARRISON. 1997. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res. 751: 217-231.
18. 5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic-depressives. Hippocampus 11: 482-491.
19. OHNUMA, T., S. TESSLER, H. ARAI, et al. 2000. Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. Mol. Brain Res. 85: 24-31.
20. EASTWOOD, S.L., P. STORY, P.W.J. BURNET, et al. 1994. Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment. J. Psychopharmacol. 80: 196-203.
21. FITZGERALD, L.W., A.Y. DEUTCH, G. GASIC, et al. 1995. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15: 2453-2461.
22. EASTWOOD, S.L., R.H.P. PORTER & P.J. HARRISON. 1996. The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain. Neurosci. Lett. 212: 163-166.
23. FREMEAU, R.T., JR., M.D. TROVER, I. PAHNER, et al. 2001. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31: 247-260.
24. HERZOG, E., G.C. BELLENCHI, C. GRAS, et al. 2001. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J. Neurosci. 21: 1-6.
25. HARRISON, P.J. & S.L. EASTWOOD. 2003. Vesicular glutamate transporter (VGLUT) gene expression provides further evidence for glutamatergic synaptic pathology in the hippocampus in schizophrenia [Abstract]. Schizophr. Res. 60: 62-63.
26. HARRISON, P.J. & S.L. EASTWOOD. 1998. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352: 1669-1673.
27. EASTWOOD, S.L. & P.J. HARRISON. 2000. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol. Psychiatry 5: 425-432.
28. SAWADA, K., A. BARR, S. TAKAHASHI, et al. 2003. Complexins I and II in hippocampus in schizophrenia [Abstract]. Schizophr. Res. 60: 74-75.
29. NEDERGAARD, M., T. TAKOMA & A.J. HANSEN. 2002. Beyond the role of glutamate as a neurotransmitter. Nature Neurosci. Rev. 3: 748-755.
30. LÜSCHER, C. & M. FRERKING. 2001. Restless AMPA receptors: implications for synaptic neurotransmission and plasticity. Trends Neurosci. 24: 665-670.
31. WENTHOLD, R.J., K. PRYBYLOWSKI, S. STANDLEY, et al. 2003. Trafficking of NMDA receptors. Annu. Rev. Pharmacol. Toxicol. 43: 335-358.
32. DEAN B., E. SCARR, R. BRADBURY & D. COPOLOV. 1999. Decreased hippocampal (CA3) NMDA receptors in schizophrenia. Synapse 32: 67-69.
33. DEAKIN, J.F.W., P. SLATER, M.D.C. SIMPSON, et al. 1989. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52: 1781-1786.
34. BREESE, C.R., R. FREEDMAN & S. LEONARD. 1995. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 674: 82-90.
35. HARRISON, P.J. & S.L. EASTWOOD. 2001. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11: 508-519.
36. BENES, F.M. 2000. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Rev. 31: 251-269.
37. PELLEGRINI-GIAMPIETRO, D., R.S. ZUKIN, M.V.L. BENNETT, et al. 1992. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. USA 89: 10499-10503.
38. HOLINGER, D., A. GALABURDA & P.J. HARRISON. 2000. Cerebral asymmetry. In The Neuropathology of Schizophrenia. Progress and Interpretation. P.J. Harrison & G.W. Roberts, Eds.: 151-171. Oxford University Press. Oxford.
39. KERWIN, R.W., S. PATEL, B.S. MELDRUM, et al. 1988. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet I: 583-584.
40. MCCULLUM SMITH, R. & J. MEADOR-WOODRUFF. 2003. Expression of vesicular glutamate transporters one and two in medial temporal lobe structures in schizophrenia, bipolar disorder, and major depressive disorder [Abstract]. Schizophr. Res. 60 (suppl.): 65.
41. NOGA, T.J. & H. WANG. 2002. Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia. Synapse 45: 250-258.
42. HARRISON, P.J. 1999. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 122: 593-624.
43. HARRISON, P.J. & M.J. OWEN. 2003. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361: 417-419.